Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-01-25

FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for CLARITIN-D 12 HOUR (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin-D 12 Hour (loratadine and pseudoephedrine sulfate)

Snippet

SUPPL AP for CLARITIN-D 12 HOUR (LORATADINE AND PSEUDOEPHEDRINE SULFATE)